Analysts Set Mediclinic International PLC (MDC) Target Price at $690.22

Mediclinic International PLC (LON:MDC) has been given an average recommendation of “Hold” by the ten research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is GBX 690.22 ($9.54).

A number of analysts have weighed in on MDC shares. Credit Suisse Group decreased their target price on shares of Mediclinic International from GBX 783 ($10.82) to GBX 630 ($8.70) and set a “neutral” rating on the stock in a research note on Monday, November 20th. Citigroup reaffirmed a “neutral” rating on shares of Mediclinic International in a research note on Tuesday, November 21st. Jefferies Group raised shares of Mediclinic International to a “buy” rating and boosted their target price for the stock from GBX 550 ($7.60) to GBX 616 ($8.51) in a research note on Thursday, November 30th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 695 ($9.60) target price on shares of Mediclinic International in a research note on Tuesday, December 12th. Finally, UBS cut shares of Mediclinic International to a “neutral” rating and boosted their target price for the stock from GBX 600 ($8.29) to GBX 650 ($8.98) in a research note on Tuesday, January 30th.

Mediclinic International (LON MDC) opened at GBX 576.40 ($7.96) on Friday. Mediclinic International has a 1 year low of GBX 495.40 ($6.84) and a 1 year high of GBX 890.18 ($12.30). The stock has a market cap of $4,390.00 and a P/E ratio of 6,404.44.

WARNING: “Analysts Set Mediclinic International PLC (MDC) Target Price at $690.22” was posted by Stock Observer and is owned by of Stock Observer. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://www.thestockobserver.com/2018/03/20/analysts-set-mediclinic-international-plc-mdc-target-price-at-690-22.html.

Mediclinic International Company Profile

Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.

Analyst Recommendations for Mediclinic International (LON:MDC)

Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply